Rubius Therapeutics
(OTC) RUBY
Rubius Therapeutics Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$233.75M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
RUBY News
RUBY: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Rubius Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
6
CEO
Dannielle Appelhans, MBA
Website
www.rubiustx.comHeadquarters
Cambridge, MA 02139, US
RUBY Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-2%
Return on Capital
-12%
Return on Assets
-10%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$178.45M
EBITDA
$169.55M
Operating Cash Flow
$150.14M
Capital Expenditure
$5.30M
Free Cash Flow
$155.45M
Cash & ST Invst.
$18.93M
Total Debt
$1.10M
Rubius Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
6
N/A
Net Income
$41.28M
+25.0%
EBITDA
$20.28M
+57.8%
Quarterly Fundamentals
Net Cash
$17.84M
-84.1%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$1.10M
-87.8%
Return on Assets
-10.01%
N/A
Return on Invested Capital
-11.79%
N/A
Free Cash Flow
$32.78M
+15.0%
Operating Cash Flow
$32.52M
+12.6%